tiprankstipranks

Steven Mento Insider Profile

4 Followers
Steven Mento, President & CEO, Director at Histogen, holds 82.28K shares in Histogen (Ticker: HSTO), holds ― shares in Dermata Therapeutics (Ticker: DRMA), holds 46.55K shares in Sangamo Biosciences (Ticker: SGMO).
tipranks
Steven Mento

Steven Mento
Histogen (HSTO)
President & CEO, Director

Ranked #68,198 out of 98,743 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-22.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$38K
65.59%
34.41%
0.00%
A breakdown of Steven Mento's holdings

Insider Roles

Sangamo Biosciences
(SGMO)
Director
Histogen
(HSTO)
President & CEO, Director
Dermata Therapeutics
(DRMA)
Director
Roles that Steven Mento holds in companies

Most Profitable Insider Trade

Stock:
Histogen
(HSTO)
Rating:Informative Buy
Date:Dec 22, 2016 - Dec 22, 2017
Return:+32.30%
The most profitable trade made by Steven Mento

Steven Mento's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Histogen
May 27, 2020
President & CEO, Director
Uninformative Buy
17.60K
$13.16K
Dermata Therapeutics
Director
Sangamo Biosciences
Jun 12, 2018
Director
Uninformative Buy
$25.09K
List of latest transactions for each holding click on a transaction to see Steven Mento's performance on stock

Steven Mento insider profile FAQ

What is the percentage of profitable transactions made by Steven Mento?
The percentage of profitable transactions made by Steven Mento is 50%.
    What is the average return per transaction made by Steven Mento?
    The average return per transaction made by Steven Mento is -22.20%.
      What stocks does Steven Mento hold?
      Steven Mento holds: HSTO, DRMA, SGMO stocks.
        What was Steven Mento’s latest transaction?
        Steven Mento latest transaction was an Uninformative Buy of $17.60K.
          What was Steven Mento's most profitable transaction?
          Steven Mento’s most profitable transaction was an Informative Buy of HSTO stock on December 22, 2016. The return on the trade was 32.30%.
            What is Steven Mento's role in Histogen?
            Steven Mento's role in Histogen is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.